$7.65 Billion is the total value of HHLR ADVISORS, LTD.'s 85 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | BEIGENE LTDsponsored adr | $1,986,430,000 | +5.8% | 5,472,259 | 0.0% | 25.98% | +34.4% | |
| IQ | IQIYI INCsponsored ads | $310,347,000 | -48.5% | 38,648,477 | 0.0% | 4.06% | -34.5% | |
| BBIO | BRIDGEBIO PHARMA INC | $251,318,000 | -23.1% | 5,362,014 | 0.0% | 3.29% | -2.3% | |
| DASH | DOORDASH INCcl a | $246,414,000 | +15.5% | 1,196,300 | 0.0% | 3.22% | +46.8% | |
| MDLZ | MONDELEZ INTL INCcl a | $108,341,000 | -6.8% | 1,862,164 | 0.0% | 1.42% | +18.4% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $105,619,000 | -34.7% | 713,400 | 0.0% | 1.38% | -17.1% | |
| VIPS | VIPSHOP HOLDINGS LIMITEDsponsored ads a | $99,856,000 | -44.5% | 8,963,752 | 0.0% | 1.31% | -29.5% | |
| GOSS | GOSSAMER BIO INC | $93,282,000 | +54.8% | 7,420,974 | 0.0% | 1.22% | +96.8% | |
| BEKE | KE HLDGS INCsponsored ads | $91,521,000 | -61.7% | 5,012,100 | 0.0% | 1.20% | -51.3% | |
| PLTK | PLAYTIKA HLDG CORP | $90,646,000 | +15.9% | 3,280,699 | 0.0% | 1.19% | +47.3% | |
| AMG | AFFILIATED MANAGERS GROUP IN | $50,626,000 | -2.0% | 335,073 | 0.0% | 0.66% | +24.4% | |
| TIL | INSTIL BIO INC | $42,640,000 | -7.5% | 2,385,457 | 0.0% | 0.56% | +17.7% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $40,249,000 | -7.1% | 360,495 | 0.0% | 0.53% | +17.9% | |
| BZ | KANZHUN LIMITEDsponsored ads | $37,790,000 | -9.2% | 1,050,000 | 0.0% | 0.49% | +15.2% | |
| LYEL | LYELL IMMUNOPHARMA INC | $34,765,000 | -8.9% | 2,348,965 | 0.0% | 0.46% | +15.8% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $33,259,000 | -18.2% | 2,920,023 | 0.0% | 0.44% | +3.8% | |
| NIO | NIO INCspon ads | $30,613,000 | -33.0% | 859,200 | 0.0% | 0.40% | -15.1% | |
| HTHT | HUAZHU GROUP LTDsponsored ads | $26,548,000 | -13.2% | 578,902 | 0.0% | 0.35% | +10.2% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $25,509,000 | -6.8% | 1,100,000 | 0.0% | 0.33% | +18.4% | |
| ACMR | ACM RESH INC | $24,594,000 | +7.6% | 223,585 | 0.0% | 0.32% | +37.0% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $20,560,000 | -1.5% | 800,000 | 0.0% | 0.27% | +25.1% | |
| RGNX | REGENXBIO INC | $19,116,000 | +7.9% | 456,000 | 0.0% | 0.25% | +37.4% | |
| SNOW | SNOWFLAKE INCcl a | $19,053,000 | +25.1% | 63,000 | 0.0% | 0.25% | +58.6% | |
| PRLD | PRELUDE THERAPEUTICS INC | $18,229,000 | +9.1% | 583,333 | 0.0% | 0.24% | +38.4% | |
| MLCO | MELCO RESORTS AND ENTMNT LTDadr | $17,397,000 | -38.2% | 1,698,877 | 0.0% | 0.23% | -21.4% | |
| SOHU | SOHU COM LTDsponsored ads | $16,714,000 | +12.0% | 802,034 | 0.0% | 0.22% | +42.2% | |
| DYN | DYNE THERAPEUTICS INC | $16,240,000 | -22.8% | 1,000,000 | 0.0% | 0.21% | -2.3% | |
| IPSC | CENTURY THERAPEUTICS INC | $15,451,000 | -14.2% | 614,095 | 0.0% | 0.20% | +9.2% | |
| ROOT | ROOT INC | $13,702,000 | -51.3% | 2,600,000 | 0.0% | 0.18% | -38.3% | |
| EM | SMART SH GLOBAL LTDads | $13,627,000 | -45.0% | 4,080,000 | 0.0% | 0.18% | -30.2% | |
| ADCT | ADC THERAPEUTICS SA | $13,580,000 | +11.5% | 500,000 | 0.0% | 0.18% | +42.4% | |
| BEDU | BRIGHT SCHOLAR ED HLDGS LTDsponsored ads | $11,439,000 | -32.3% | 3,985,797 | 0.0% | 0.15% | -13.8% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $10,296,000 | -5.1% | 277,754 | 0.0% | 0.14% | +20.5% | |
| MOGU | MOGU INCspon ads | $10,134,000 | -41.6% | 10,446,970 | 0.0% | 0.13% | -25.7% | |
| PATH | UIPATH INCcl a | $7,892,000 | -22.6% | 150,000 | 0.0% | 0.10% | -1.9% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $7,202,000 | -23.7% | 2,976,121 | 0.0% | 0.09% | -3.1% | |
| UXIN | UXIN LTDads | $6,341,000 | -28.3% | 2,297,318 | 0.0% | 0.08% | -8.8% | |
| RXDX | PROMETHEUS BIOSCIENCES INC | $4,742,000 | -3.5% | 200,000 | 0.0% | 0.06% | +21.6% | |
| DSGN | DESIGN THERAPEUTICS INC | $4,128,000 | -26.1% | 280,991 | 0.0% | 0.05% | -6.9% | |
| CVET | COVETRUS INC | $2,814,000 | -32.8% | 155,124 | 0.0% | 0.04% | -14.0% | |
| SFUN | FANG HLDGS LTDadr new | $2,065,000 | -46.8% | 327,720 | 0.0% | 0.03% | -32.5% | |
| YSG | YATSEN HLDG LTDads | $955,000 | -59.4% | 250,764 | 0.0% | 0.01% | -50.0% | |
| LEAPU | RIBBIT LEAP LTDunit 99/99/9999 | $523,000 | -5.9% | 50,000 | 0.0% | 0.01% | +16.7% | |
| CIH | CHINA INDEX HLDGS LTDspnsrd ads a | $438,000 | -27.4% | 300,000 | 0.0% | 0.01% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.